University of Chicago Radiation Oncology
@UChicagoRadonc
Followers
666
Following
172
Media
23
Statuses
234
Department of Radiation and Cellular Oncology at The University of Chicago. @UChicago @UChicagoMed #RadOnc
Chicago, IL
Joined July 2014
Very grateful for the opportunity and the great mentorship at @UChicagoRadonc. Special thanks to @RohanKatipally for all the support!
Proud of superstar resident, Dr. Abed Kawakibi @AbedKawakibi, presenting how ctDNA may improve surveillance of HPV+ oropharyngeal cancer after chemoradiation at @ASTRO_org — work emerging from treatment de-escalation protocols at our UChicago Head & Neck Cancer Program!
0
1
2
Proud of superstar resident, Dr. Abed Kawakibi @AbedKawakibi, presenting how ctDNA may improve surveillance of HPV+ oropharyngeal cancer after chemoradiation at @ASTRO_org — work emerging from treatment de-escalation protocols at our UChicago Head & Neck Cancer Program!
3
6
25
Congrats to our very own Steve Chmura (@Docace911) for his role on the @AACR Cancer Progress Report 2025 Steering Committee! #radonc #cancer
The AACR Cancer Progress Report 2025 is the 15th edition of this report, highlighting research-driven advances in cancer medicine. Survivors featured in previous reports shared how they've been impacted by cancer research on the #AACRBlog. https://t.co/hJGceThw3B
0
1
4
UChicago is recruiting for a faculty radiation oncologist position. We'll be meeting candidates at ASTRO 2025. Check out our posting: https://t.co/8TOK1pHvNA EEO/Vet/Disability #radonc #ASTRO
0
0
4
UChicago is recruiting for a faculty radiation oncologist position. We'll be meeting candidates at ASTRO 2025. Check out our posting: https://t.co/AS24P9ZkAB
#radonc #ASTRO
careers.astro.org
View jobs available on American Society for Radiation Oncology. Search for and apply to open jobs from American Society for Radiation Oncology.
1
4
9
Check out the excellent perspective published by Sean Pitroda, MD, and colleagues in @NatureGenet, highlighting how high aneuploidy scores predict immunotherapy response and can help guide personalized cancer treatment. @UChicagoRadonc @UChicagoMed
https://t.co/Cfz4KiWJEV
uchicagomedicine.org
A new study shows how combining immunotherapy with radiation may help overcome the issue of therapy resistance, offering a new framework for predicting treatment response and personalizing cancer...
0
4
9
New study from @rweichselbaum and team show high-dose radiation triggers amphiregulin, a protein that weakens immunity and fuels distant cancer spread—pointing to new strategies for blocking its effects. @SeanPitroda @AndrasPiffko @UChicagoRadonc @Nature
https://t.co/MIHrXFATrB
0
5
5
Excited to share our recent @Nature paper! https://t.co/ZPfEqgqXcZ Tremendous collaborative effort from @UCCancerCenter @UChicago @UChicagoRadonc @rweichselbaum
nature.com
Nature - Radiotherapy induces expression of the EGFR ligand amphiregulin, which promotes metastasis growth at remote sites in mouse models and human patients by shifting myeloid cells towards an...
14
43
159
Facts and hopes in radioimmunotherapy of oligometastatic disease https://t.co/HK0K5QMGmA Excellent review by @UChicagoRadonc residents Daniel Huang and Connor Lynch @rweichselbaum @UCCancerCenter
1
5
19
Terrific visit today from @UMichRadOnc 's Dr. Ted Lawrence, pictured here with our Rad Onc residents.
1
2
22
Congrats to our incoming Chief Resident @J0hnMWhite for his EAGL honors!
Honored to be recognized with the Emerging Advocacy Grassroots Leadership (EAGL) Award! Advocacy has always been at the heart of my journey—whether in medicine, the military, or policy.
1
1
3
April marks #NationalCancerControlMonth. Cancer screenings can provide early detection and can help control cancers at their earliest and most treatable stages. @UChicagoMed @UChicagoHemOnc @UChicagoBreast @UChicagoRadonc @UChicagoOHNS
What is cancer screening? Screenings are tests that can prevent cancer by finding it before you have symptoms. It can also find cancer early when treatment likely works best. The right screening at the right time can save lives. Get your screening today: https://t.co/WIf7DKhaFM
0
3
8
We are thrilled to announce our newly-matched 2030 class of radiation oncology residents: Chad Caraway, Alexander Cooke, and Azan Haque. Welcome! @HaqueAzan
2
3
21
Where does #immunotherapy stand in the treatment of metastatic cancers? Is it the only and best choice? Check out the insights shared by @UChicagoRadonc experts @rweichselbaum and @SeanPitroda here: https://t.co/BgNe6lRgwN
@UChicagoMed @UCCancerCenter @UChicagoHemOnc
2
4
12
Great work by PGY5 resident @ConnorLynchMD on pooling and reporting on prospectively collected clinical trial data to guide clinicians on the safety of multi-site SBRT and immunotherapy in patients with metastatic disease @UCCancerCenter @UChicagoRadonc
Online now: our report in EJC compiles toxicity data from 213 pts across 3 multi-site SBRT + immune checkpoint inhibitor trials at UChicago to characterize the toxicity profile of combined modality treatment:
2
1
4
New Review in the August issue: Radiotherapy, immunity, and immune checkpoint inhibitors #radiotherapy #ImmuneCheckpointInhibitors
https://t.co/4wVAClMfPD
1
9
13
Another fantastic article written by the extremely talented @ConnorLynchMD ! https://t.co/T9gvPcSaQl
@rweichselbaum @TheLancetOncol @Ludwig_Cancer @UChicago @UCCancerCenter @UChicagoRadonc
4
11
35
Aditya Jullori, MD chairs a Clinical Science Symposium Session - “Making the Cut: Decision Support Tools in Surgically Treated HPV+ Oropharyngeal Cancer.” #ASCO24
@ajuloorimd @UChicagoRadonc @UChicagoOHNS @UCCancerCenter @UChicagoHemOnc
0
8
22